This bifunctional protein plays a crucial role in lysophospholipid acylation. It catalyzes the transfer of fatty acids to the 1-position of lysophospholipids via an enzyme-bound acyl-ACP intermediate, requiring ATP and magnesium ions. Its physiological function is the regeneration of phosphatidylethanolamine from 2-acyl-glycero-3-phosphoethanolamine (2-acyl-GPE), a byproduct of transacylation reactions or phospholipase A1 degradation.
KEGG: esa:ESA_00472
STRING: 290339.ESA_00472
The Aas protein in C. sakazakii functions as a bifunctional enzyme with dual activities: 2-acylglycerophosphoethanolamine acyltransferase and acyl-ACP synthetase. While not explicitly detailed in the search results, this bifunctional protein likely plays roles in:
Phospholipid remodeling through the transfer of acyl groups
Fatty acid activation via the synthetase function
This protein may contribute to membrane maintenance and adaptation to environmental stresses, which is particularly relevant given C. sakazakii's ability to persist in various environments, including low-moisture conditions that make it problematic in powdered infant formula .
While the Aas protein is not specifically identified among the confirmed virulence factors in the search results, C. sakazakii pathogenicity involves multiple factors. Recent research has identified several virulence-associated proteins in C. sakazakii, including FabH, GshA, GppA, GcvH, IhfB, RfaC, and MsyB . The Aas protein may interact with these pathways, particularly since it likely functions in lipid metabolism, which can affect bacterial membrane integrity and adaptation to host environments.
Research indicates that the regulatory genes rcsA and treR influence C. sakazakii toxicity in zebrafish and rat models . Understanding how Aas expression is regulated, possibly by these or other transcriptional regulators, would provide insights into its potential role in virulence.
For optimal expression of recombinant C. sakazakii Aas protein:
Expression System: E. coli is the recommended host for expression
Construct Design: Full-length protein (1-719 amino acids) should be expressed for complete functionality
While specific expression conditions are not detailed in the search results, standard E. coli expression protocols would typically involve:
Induction with IPTG (0.1-1.0 mM)
Temperature optimization (often 16-37°C depending on protein solubility)
Growth in rich media (such as LB or TB)
Expression time optimization (4-24 hours)
Based on the His-tagged nature of the recombinant protein, a multi-step purification protocol is recommended:
Initial Capture: Immobilized metal affinity chromatography (IMAC) using Ni-NTA or similar resin to capture the His-tagged protein
Intermediate Purification: Size exclusion chromatography to separate the protein from aggregates and impurities
Quality Assessment: SDS-PAGE to confirm purity (>90% purity is achievable)
The purified protein is typically supplied as a lyophilized powder for stability .
For optimal handling and storage of recombinant Aas protein:
Reconstitution Protocol:
Centrifuge the vial briefly to collect contents
Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 5-50% (recommended 50%) for long-term storage
Storage Conditions:
Store at -20°C/-80°C upon receipt
Prepare working aliquots to avoid repeated freeze-thaw cycles
Working aliquots can be stored at 4°C for up to one week
Long-term storage requires -20°C/-80°C with glycerol as a cryoprotectant
The protein is provided in a Tris/PBS-based buffer containing 6% Trehalose at pH 8.0 .
For assessing the dual enzymatic activities of the Aas protein:
Acyltransferase Activity Assay:
Substrate preparation: 2-acylglycerophosphoethanolamine and acyl-CoA donors
Reaction monitoring: HPLC or LC-MS to track substrate conversion and product formation
Spectrophotometric assays: Coupling release of CoA with chromogenic reagents
Acyl-ACP Synthetase Activity Assay:
Substrate preparation: Free fatty acids, ATP, and ACP
Monitoring ATP consumption: Luciferase-based ATP detection
Product detection: Native PAGE to visualize acylated ACP species
While the specific enzymatic parameters for the C. sakazakii Aas protein are not provided in the search results, these methodological approaches are consistent with standard biochemical characterization techniques for similar bifunctional enzymes.
To establish structure-function relationships:
Domain Mapping: Bioinformatic analysis to identify conserved domains for each function
Site-Directed Mutagenesis: Create targeted mutations in predicted catalytic residues
Truncation Analysis: Generate domain-specific constructs to isolate individual functions
Crystal Structure Determination: X-ray crystallography or cryo-EM to resolve 3D structure
Molecular Dynamics Simulations: Computational analysis of protein dynamics
These approaches would help delineate which regions of the 719-amino acid protein are responsible for the acyltransferase versus synthetase activities and identify critical residues for catalysis.
C. sakazakii is known for its ability to persist in low-moisture environments, contributing to its presence in powdered infant formula . While specific data on Aas protein's role is not detailed in the search results, researchers investigating this relationship should consider:
Desiccation Tolerance Assays: Compare survival rates between wild-type and Aas-knockout strains under low-moisture conditions
Membrane Composition Analysis: Investigate changes in phospholipid profiles in response to environmental stresses
Gene Expression Studies: Measure aas gene expression under various environmental conditions using RT-qPCR
Comparative Genomics: Analyze aas gene conservation across C. sakazakii strains with variable environmental persistence
Recent research on RecA deletion has shown impacts on desiccation tolerance and environmental resilience in C. sakazakii . Similar methodologies could be applied to investigate the Aas protein's role.
Based on successful C. sakazakii virulence studies, researchers should consider:
Animal Models:
Zebrafish Model: Useful for high-throughput initial screening of virulence factors
Rat Model: Provides more translational relevance to human infections
Experimental Approaches:
Gene Knockout Studies: Generate Aas-deficient mutants and complemented strains
Survival Analysis: Monitor host survival rates after infection with wild-type versus mutant strains
Bacterial Load Quantification: Measure bacterial counts in blood and tissues
Histopathological Examination: Assess tissue damage and inflammatory responses
Transcriptomic Analysis: Identify genes co-regulated with aas during infection
Recent studies have successfully used such approaches to identify virulence factors in C. sakazakii, including the demonstration of reduced virulence in RecA knockout mutants .
To investigate the interaction network of Aas protein:
Co-Immunoprecipitation: Using anti-His antibodies to pull down the His-tagged Aas protein and identify interacting partners
Bacterial Two-Hybrid Assays: Screening for potential protein partners
Cross-Linking Mass Spectrometry: Identifying spatial relationships between Aas and other proteins
Proximity-Dependent Biotin Identification (BioID): Mapping the proximal protein environment
These methodologies could reveal interactions with known virulence factors identified in C. sakazakii, such as FabH, GshA, or regulatory proteins like RcsA and TreR , providing insights into how Aas contributes to bacterial physiology and pathogenicity.
For inhibitor development targeting Aas protein:
High-Throughput Screening:
Enzymatic activity-based assays to screen compound libraries
Fragment-based screening to identify initial chemical scaffolds
Structure-Based Drug Design:
In silico docking studies using homology models or resolved structures
Rational design targeting catalytic sites of either enzymatic function
Evaluation in Bacterial Systems:
Growth inhibition assays with identified compounds
Membrane integrity assessments
Synergy testing with existing antibiotics
Validation in Animal Models:
Recent research identifying RecA as a promising target for mitigating C. sakazakii infections demonstrates the potential of targeting specific proteins to reduce pathogen virulence and environmental persistence .
To experimentally distinguish between the acyltransferase and synthetase activities:
Selective Substrate Utilization:
Design assays with specific substrates for each function
Monitor reaction progress using mass spectrometry or chromatographic methods
Domain-Specific Inhibitors:
Develop compounds targeting each functional domain separately
Use competitive inhibitors specific to each reaction type
Mutational Analysis:
Create targeted mutations affecting each activity independently
Measure the impact on each function using biochemical assays
Isotope Labeling Studies:
Track substrate utilization with isotope-labeled precursors
Use NMR or mass spectrometry to follow metabolic flux
This methodological approach would provide insights into whether the dual functions operate independently or exhibit regulatory cross-talk, and how each function contributes to bacterial physiology and virulence.